SCHEMBL7815817

SCHEMBL7815817

CCOCC(O)Cn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 13/20 0.63
PRKACG P22612 13/20 0.63
PRKACB P22694 13/20 0.63
CCNB2 O95067 3/20 0.63
CDK1 P06493 3/20 0.63
CCNB1 P14635 3/20 0.63
CCNB3 Q8WWL7 3/20 0.63
CDK4 P11802 5/20 0.62
CCND1 P24385 5/20 0.62
CAMK2D Q13557 6/20 0.59
CCNE2 O96020 3/20 0.59
CCNE1 P24864 3/20 0.59
CDK2 P24941 3/20 0.59
SIRT2 Q8IXJ6 2/20 0.59
GSK3B P49841 2/20 0.59
MEN1 O00255 1/20 0.59
PRKD3 O94806 1/20 0.59
TP53 P04637 1/20 0.59
PRKCG P05129 1/20 0.59
CYP1A2 P05177 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9085211 0.91 PRKACA (0.53) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9085751 0.91 PRKACA (0.53) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9085925 0.91 PRKACA (0.53) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9086251 0.91 PRKACA (0.53) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9086377 0.90 CAMK2D (0.54) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9084775 0.90 PRKACA (0.55) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9085265 0.90 PRKACA (0.52) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9087050 0.90 CDK4 (0.55) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9083675 0.90 PRKACA (0.52) PRKACAPRKACGPRKACBCCNB2CDK1
SCHEMBL9087152 0.90 PRKACA (0.52) PRKACAPRKACGPRKACBCCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP claimed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US claimed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP claimed
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP disclosed
US-5516915-A Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US disclosed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP disclosed